Keywords: Clinical trial costs, Extraneous data collection, Tufts CSDD, USA

Extraneous clinical data collection costs drug developers $4-$6 billion a year, says Tufts CSDD

Article | 06 November 2012

One out of every five procedures performed during later stage clinical trials collects extraneous data and costs drug developers more ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in